tiprankstipranks
Advertisement
Advertisement
BioStem Technologies issued four U.S. design patents for allograft technology
PremiumThe FlyBioStem Technologies issued four U.S. design patents for allograft technology
2M ago
BioStem Technologies announces notice of allowance for four patents
Premium
The Fly
BioStem Technologies announces notice of allowance for four patents
3M ago
BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright
Premium
The Fly
BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright
3M ago
BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
PremiumCompany AnnouncementsBioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
7M ago
BioStem Technologies Q3 Earnings Call Highlights Resilience
Premium
Company Announcements
BioStem Technologies Q3 Earnings Call Highlights Resilience
9M ago
BioStem Technologies Reports Q3 2025 Financial Results
Premium
Company Announcements
BioStem Technologies Reports Q3 2025 Financial Results
9M ago
BioStem Technologies Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsBioStem Technologies Reports Q2 2025 Financial Results
1y ago
BioStem Technologies’ Innovative Approach to Healing Venous Leg Ulcers: A Clinical Study Update
Premium
Company Announcements
BioStem Technologies’ Innovative Approach to Healing Venous Leg Ulcers: A Clinical Study Update
1y ago
BioStem’s BR-AM Trial: A Potential Game-Changer for Diabetic Foot Ulcers
Premium
Company Announcements
BioStem’s BR-AM Trial: A Potential Game-Changer for Diabetic Foot Ulcers
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100